Fresenius is a global healthcare group offering high-quality products and services for dialysis, hospitals, and outpatient treatment. With over 300,000 employees in more than 100 countries around the globe, and annual sales exceeding €35 billion, Fresenius is one of the world’s leading healthcare companies.
Year founded1912
Served areaWorldwide
Headcount311,269
HeadquartersElse-Kröner-Straße 1, 61352 Bad Homburg v. d. Höhe – Germany
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
04.08.23 | Moser, Dr. Michael | Board | Buy | EUR 300,565.98 |
03.04.23 | Sen, Michael | Board | Buy | EUR 586,989.25 |
03.04.23 | Hennicken, Sara | Board | Buy | EUR 49,839.92 |
18.11.22 | De Meo, Dr. Francesco | Board | Buy | EUR 50,415.29 |
29.08.22 | De Meo, Dr. Francesco | Board | Sell | EUR 50,831.20 |
05.08.22 | Sturm, Stephan | Board | Buy | EUR 119,831.44 |
05.08.22 | Sturm, Stephan | Board | Buy | EUR 119,676.59 |
05.08.22 | Schmitt, Martin | Board | Buy | EUR 5,150.00 |
10.06.22 | Sturm, Stephan | Board | Other | EUR 54,089.64 |
10.06.22 | Kirsch, Wolfgang | Supervisory board | Other | EUR 6,901.09 |
DE0005785604
LEIXDFJ0CYCOO1FXRFTQS51
SectorHealth Care Equipment & Services
IndustryHealth Care Providers & Services
Sub-IndustryDAX
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.